Literature DB >> 32025142

Utilization, effectiveness, and safety of tranexamic acid use in hip fracture surgery: A population-based study.

Zoe B Cheung1, Shawn G Anthony1, David A Forsh1, Jeremy Podolnick1, Nicole Zubizarreta2, Leesa M Galatz1, Jashvant Poeran2.   

Abstract

OBJECTIVE: To assess the effect of tranexamic acid (TXA) use in hip fracture surgery.
METHODS: A retrospective cohort study was performed using the Premier Healthcare database. A propensity score matching approach was applied to assess associations between TXA use and blood transfusion, perioperative complications, length of stay (LOS), and hospitalization cost.
RESULTS: In 153,169 patients, TXA use was associated with a 17% decrease in odds of blood transfusion, no increase in the risk of perioperative complications, 16% shorter LOS, and minimal effects on hospitalization cost.
CONCLUSION: Our results are in support of a wider use of TXA in hip fracture surgery. LEVEL OF EVIDENCE: Level III.
© 2020 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood transfusion; Complications; Hip fracture; Hospitalization cost; Tranexamic acid

Year:  2020        PMID: 32025142      PMCID: PMC6997115          DOI: 10.1016/j.jor.2020.01.040

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  31 in total

1.  Does blood transfusion increase the risk of infection after hip fracture?

Authors:  K J Koval; A D Rosenberg; J D Zuckerman; G B Aharonoff; M L Skovron; R L Bernstein; E Su; M Chakka
Journal:  J Orthop Trauma       Date:  1997-05       Impact factor: 2.512

Review 2.  Epidemiology of hip fractures.

Authors:  R G Cumming; M C Nevitt; S R Cummings
Journal:  Epidemiol Rev       Date:  1997       Impact factor: 6.222

3.  Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis.

Authors:  Zhi-Gao Yang; Wei-Ping Chen; Li-Dong Wu
Journal:  J Bone Joint Surg Am       Date:  2012-07-03       Impact factor: 5.284

4.  Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009.

Authors:  Anas Saleh; Travis Small; Aiswarya Lekshmi Pillai Chandran Pillai; Nicholas K Schiltz; Alison K Klika; Wael K Barsoum
Journal:  J Bone Joint Surg Am       Date:  2014-09-17       Impact factor: 5.284

5.  Preliminary investigation of high-dose tranexamic acid for controlling intraoperative blood loss in patients undergoing spine correction surgery.

Authors:  Jingming Xie; Lawrence G Lenke; Tao Li; Yongyu Si; Zhi Zhao; Yingsong Wang; Ying Zhang; Jie Xiao
Journal:  Spine J       Date:  2014-11-29       Impact factor: 4.166

6.  Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.

Authors:  Paul S Myles; Julian A Smith; Andrew Forbes; Brendan Silbert; Mohandas Jayarajah; Thomas Painter; D James Cooper; Silvana Marasco; John McNeil; Jean S Bussières; Shay McGuinness; Kelly Byrne; Matthew T V Chan; Giovanni Landoni; Sophie Wallace
Journal:  N Engl J Med       Date:  2016-10-23       Impact factor: 91.245

7.  Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials.

Authors:  Joan Cid; Miguel Lozano
Journal:  Transfusion       Date:  2005-08       Impact factor: 3.157

8.  Incidence and mortality of hip fractures in the United States.

Authors:  Carmen A Brauer; Marcelo Coca-Perraillon; David M Cutler; Allison B Rosen
Journal:  JAMA       Date:  2009-10-14       Impact factor: 56.272

9.  Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities.

Authors:  Daniel R Whiting; Blake P Gillette; Christopher Duncan; Hugh Smith; Mark W Pagnano; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2014-01       Impact factor: 4.176

Review 10.  Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis.

Authors:  Katharine Ker; Phil Edwards; Pablo Perel; Haleema Shakur; Ian Roberts
Journal:  BMJ       Date:  2012-05-17
View more
  4 in total

1.  The association between perioperative blood transfusions and venous thromboembolism risk following surgical management of hip fractures.

Authors:  Daniel Grits; Andy Kuo; Alexander J Acuña; Linsen T Samuel; Atul F Kamath
Journal:  J Orthop       Date:  2022-08-23

2.  Anemia at Presentation Predicts Acute Mortality and Need for Readmission Following Geriatric Hip Fracture.

Authors:  Gareth Ryan; Lauren Nowak; Luana Melo; Sarah Ward; Amit Atrey; Emil H Schemitsch; Aaron Nauth; Amir Khoshbin
Journal:  JB JS Open Access       Date:  2020-09-28

3.  The effect of tranexamic acid on the reduction of intraoperative and postoperative blood loss and thromboembolic risk in patients with hip fracture.

Authors:  Ivan B Stojadinovic; Branko M Ristic; Dragan R Knezevic; Zoran S Milenkovic; Nikola S Prodanovic; Nenad R Zornic; Jelena B Milosevic
Journal:  Open Med (Wars)       Date:  2022-04-29

4.  Quality of life and cost-effectiveness analysis of topical tranexamic acid and fibrin glue in femur fracture surgery.

Authors:  A Merchán-Galvis; M Posso; E Canovas; M Jordán; X Aguilera; M J Martinez-Zapata
Journal:  BMC Musculoskelet Disord       Date:  2022-08-31       Impact factor: 2.562

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.